baber/WOPTO huggingface dataset:
Patent IL-79333-A0 (IL)
Title: Method and kit for imaging lymphatic structures
IPC: G01T1/161
Filed: 1986-07-04
Abstract: An improved method for lymphoscintigraphy or magnetic resonance lymphography involves subtraction of a negative image produced using a gross imaging agent from a positive image produced with a specific antibody imaging agent. Another embodiment of the invention uses an antibody to lymphatic tissue as an imaging agent for lymphatics. A further embodiment uses a magnetic resonance image enhancing agent for magnetic resonance lymphography.Reagents and kits for use in the foregoing method are also provided.
Patent IL-88347-A0 (IL)
Title: Progressive intensity phase plate bifocal
IPC: G02B5/18
Filed: 1988-11-10
Abstract: An ophthalmic contact lens containing more than one phase plate within its optic zone, including contact lens, especially of a Cohen lens design, which possesses phase plate optics within its optic zone that progressively shift the intensity of light focussed by bifocal phase plates between the diffractive focal powers by utilizing echelettes in the phase plates of varying depths and heights which are cooperatively aligned relative to the lens base curve surface that they openly face.
Patent IL-96791-A0 (IL)
Title: Karl-fischer reagent and a process for the determination of water with the aid of this reagent
IPC: G01N31/22
Filed: 1990-12-26
Abstract: Karl Fischer reagent and a method for the determination of water using this reagent which, instead of iodine, contains an approximately equimolar quantity of iodine halides and salts of aromatic nitrogen heterocyclic compounds.
Patent IL-97788-A0 (IL)
Title: Inhibition of allograft and concordant xenograft rejection
IPC: A61K38/00
Filed: 1991-04-08
Abstract: Cyclosporin A, or another compound having cyclosporin A-like activity, and cobra venom factor, or another complement inhibitor, can be used in conjunction with each other to promote allograft and concordant xenograft survival and to rescue such grafts from rejection.
Patent FI-20002078-A0 (FI)
Inventor: SYRJAELAE JARI
IPC: H04W4/24
Filed: 2000-09-20
Abstract: The invention relates to a method and a system implementing the method for arranging subscriber billing in a multi-provider environment wherein a subscriber desiring a service uses both a first network (A) and a second network (T). In order to bill the subscriber, either a tariff of the second network (T) is transmitted to the first network (A), a tariff of the first network is combined with the tariff of the second network and the subscriber is billed according to the combined tariff, or a billing identifier is generated in the first network (A) to be transmitted to the second network (T), the billing identifier is attached to billing information in both networks and the pieces of the billing information that comprise the same billing identifier are combined in order to bill the subscriber. The invention thus enables a subscriber in a multi-provider environment to be billed using a single bill.
Patent FI-20075910-A0 (FI)
Inventor: NISSILAE JUUSO
IPC: A61B/
Filed: 2007-12-14
Abstract: There is provided an electronic device comprising: a processing unit (110) configured to receive skin temperature data generated by a measuring unit, to receive performance data from a measuring unit, and to determine a theoretical fluid loss value on the basis of the received performance data. The electronic device further comprises: a processing unit (110) configured to determine a relation between a predetermined perspiration threshold and a skin temperature value deduced from the received skin temperature data; and to determine a real fluid loss value on the basis of the theoretical fluid loss value and the determined relation between the predetermined perspiration threshold and the skin temperature value.
Patent IL-101233-A0 (IL)
Title: Receptor-based screening methods for amylin agonists and antagonists
IPC: C07K14/705
Filed: 1992-03-15
Abstract: Methods for identifying or screening or characterizing or assaying or isolating known or candidate agonists and antagonists of amylin, comprising binding assays utilizing preparations containing specific receptors for amylin. Membranes from the brain that contain high density receptors for amylin are particularly useful for the methods of this invention, and as a source of amylin receptors.
Patent IL-135180-A0 (IL)
Title: Sulfonyl derivatives
IPC: C07D401/10
Filed: 1998-09-30
Abstract: Described is a sulfonyl derivative represented by the following formula (I): <CHEM> Äwherein R<1> represents a hydrogen atom, a hydroxyl group, a nitro group or the like, R<2> and R<3> each independently represents a hydrogen atom, a halogen atom or the like, R<4> and R<5> each independently represents a hydrogen atom, a halogen atom or the like, Q<1> represents a saturated or unsaturated 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like, Q<2> represents a single bond, an oxygen atom or the like, Q<3> represents any one of the following groups: <CHEM> T<1> represents a carbonyl group or the like, and X<1> and X<2> each independently represents a methine group or a nitrogen atomÜ; or salt thereof; or solvate thereof. The sulfonyl derivative, salt or solvate according to the present invention is novel as an excellent anticoagulant and it has strong FXa inhibitory action, rapidly exhibits sufficient and long-lasting anti-thrombus effects after oral administration and has less side effects.
Patent IL-137260-A0 (IL)
Title: Method and apparatus for detecting molecular binding events
IPC: G01N37/00
Filed: 1999-02-01
Abstract: Systems and methods for detecting molecular binding events and other environmental effects using the unique dielectric properties of the bound molecular structure or structures are presented. A molecular binding layer is coupled along the surface of a signal path. A test signal is propagated along the signal path, whereby the test signal couples to the molecular binding layer, and in response, exhibits a signal response.
Patent IL-140665-A0 (IL)
Title: Antihypersensitive combination of valsartan and calcium channel blocker
IPC: A61P9/12
Filed: 1999-07-09
Abstract: The invention relates to a method for the treatment or prevention of a condition or disease selected from the group consisting of hypertension, (acute and chronic) congestive heart failure, left ventricular dysfunction and hypertrophic cardiomyopathy, myocardial infarction and its sequelae, supraventricular and ventricular arrhythmias, atrial fibrillation or atrial flutter, atherosclerosis, angina (whether stable or unstable), renal insufficiency (diabetic and non-diabetic), heart failure, angina pectoris, diabetes, hypertension in patients with NIDDM, secondary aldosteronism, primary and secondary pulmonary hyperaldosteronism, primary and pulmonary hypertension, renal failure conditions, such as diabetic nephropathy, glomerulonephritis, scleroderma, glomerular sclerosis, proteinuria of primary renal disease, and also renal vascular hypertension, diabetic retinopathy, the management of other vascular disorders, such as migraine, Raynaud's disease, luminal hyperplasia, cognitive dysfunction (such as Alzheimer's), and stroke, comprising administering a therapeutically effective amount of combination of (i) the AT 1 -antagonists valsartan or a pharmaceutically acceptable salt thereof and (ii) a Calcium channel blocker or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier to a mammal in need of such treatment and to corresponding pharmaceutical combination composition.
Patent IL-143281-A0 (IL)
Title: Method and apparatus for concurrent dbms table operations
IPC: G06F12/00
Filed: 1999-11-24
Abstract: Database tables are unloaded by launching a number of threads corresponding to a number of export directories located on separate storage devices that maintain the database tables. Each thread is assigned a database table to unload, and data unloaded from each database table is stored in a corresponding export directory. The data is unloaded from each database table by reading data storage blocks from each table and storing the data logs in the export directory. Each thread is handled by a separate process in a Symmetrical Multi-Processing (SMP) environment. The process is repeated until each database table has been unloaded. The data is then loaded into database tables by first creating a number of temporary tables corresponding to the number of threads, reading a set of data stored in the export directory and storing the data read in a corresponding of the temporary tables by launching a load process for each temporary table. If at any time either the load or unload process is faulted or becomes inoperative, the processes are stopped and an internal TS reorganization concurrent is performed on each table that has not been unloaded and loaded successfully.
Patent IL-144300-A0 (IL)
Title: Method for making a non-contact hybrid smart card with an antenna support made of fibrous material
IPC: B42D15/10
Filed: 2000-11-28
Abstract: The present invention relates to a hybrid-contact contactless smart card manufacturing process and specifically a manufacturing process for hybrid-contact contactless smart card in which the antenna is on a fibrous material such as paper. This process includes a manufacturing step to screen print the antenna onto the support, a step to laminate the card body onto the antenna support by hot press molding, a step to mill a cavity in the card body opposite the side of the support bearing the screen print for housing a module comprised of a chip and a double-sided circuit and a step for inserting the module in the card. Cutouts made in the corners of the antenna support prior to the lamination step enable the card bodies to be bonded together. The card thus obtained allows a posteriori viewing of any mechanical misuse to which it may have been subjected (extreme bending).
Patent IL-150640-A0 (IL)
Title: Novel use of phenylheteroalkylamine derivatives
IPC: C07C255/58
Filed: 2001-02-20
Abstract: There is disclosed the use of a compound of formula (I), wherein R<SUP>1</SUP>, R<SUP>2</SUP>, X, Y, V, W and Z are as defined in the specification, and pharmaceutically acceptable salts, enantiomers or racemates thereof, in the manufacture of a medicament, for the treatment or prophylaxis of diseases or conditions in which inhibition of nitric oxide synthase activity is beneficial. Certain novel compounds of formula (Ia) and pharmaceutically acceptable salts thereof, and enantiomers and racemates thereof are disclosed; together with processes for their preparation, compositions containing them and their use in therapy. The compounds of formulae (I) and (Ia) are inhibitors of the enzyme nitric oxide synthase and are thereby particularly useful in the treatment or prohylaxis of inflammatory disease
Patent IL-159339-A0 (IL)
Title: Wound dressing and method for controlling severe, life-threatening bleeding
IPC: A61L15/16
Filed: 2002-06-14
Abstract: Dental dressing assemblies are formed from hydrophilic polymer sponge structures, such as a densified chitosan biomaterial. The invention also contemplates systems and methods that can be used in conjunction with stents and periodontal dressings to promote hemostasis and secondary healing in free gingival graft palatal donor sites and all other oral and maxillofacial surgical sites.
Patent IL-159684-A0 (IL)
Title: Automated system and method for processing multiple liquid-based specimens
IPC: B01L3/14
Filed: 2002-10-21
Abstract: An automated system and method for individually processing multiple specimens of particulate matter-containing liquid in respective containers. The containers are transported seriatim along a processing path to present them to, at least, a preprocessing apparatus (e.g., a mixing head), and then to a specimen acquisition apparatus, which removes preprocessed specimen fluid from the container for subsequent analytical testing or evaluation. Each apparatus is actuated in response to presentation of a container thereto so as to carry out its respective operation independently. An exemplary system can include, in sequential order, stations for container loading and unloading, container uncapping and cap disposal, specimen mixing, filter loading, specimen acquisition (e.g., by aspiration, and then slide printing), filter disposal, and container resealing. The system is capable of unattended operation for many hours at a time, and can interface with an integrated data management system to provide fully integrated specimen and information management in a complete diagnostic laboratory system.
Patent IL-175161-A0 (IL)
Title: Roller sear/hammer interface for firearms
IPC: F41A19/12
Filed: 2006-04-25
Abstract: A roller sear/hammer interface for a firearm. The sear (11) has a roller (17) rotatably mounted between two side plates (16) forming a portion of the sear body (14). As the trigger (13) is moved, a linkage (12) connecting the trigger (13) and sear (11) causes the sear (11) to pivot rearward such that the roller (17) engages a notched surface (22) formed in the hammer (21). This rolling action releases the hammer (21) to strike a firing pin (24) to fire a round of ammunition. When the trigger (13) is released, the sear roller (17) rolls downward into an engaged and locked position within the notch (22) formed in the hammer (21).
Patent IL-219496-A0 (IL)
Title: Chemical-mechanical polishing composition and method for using the same
IPC: C09G1/02
Filed: 2012-04-30
Abstract: The invention provides methods of polishing a noble metal-containing substrate with one of two chemical-mechanical polishing compositions. The first chemical-mechanical polishing composition comprises (a) an abrasive comprising α-alumina, (b) about 0.05 to about 50 mmol/kg of ions of calcium, strontium, barium, or mixtures thereof, and (c) a liquid carrier comprising water. The second chemical-mechanical polishing composition comprises (a) an abrasive selected from the group consisting of α-alumina, γ-alumina, δ-alumina, θ-alumina, diamond, boron carbide, silicon carbide, tungsten carbide, titanium nitride, and mixtures thereof, (b) about 0.05 to about 3.5 mmol/kg of ions of calcium, strontium, barium, magnesium, zinc, or mixtures thereof, and (c) a liquid carrier comprising water.
Patent RO-125279-A0 (RO)
Title: Process for preparing bioactive complexes of hedera helix herba and medicine product to be used in anti-tumour therapy
Inventor: MANZATU LILIANA
IPC: A61P31/00
Filed: 2009-10-26
Abstract: The invention relates to a phytotherapeutic product, a process for preparing the same and a medicine containing the same, used in the anti-tumor therapy. According to the invention, the phytotherapeutic product contains at least 90% of total triterpene monodesmoside saponins, aglycon hederagenin, of which 70...80% alpha-hederin, usable for preparing some bioactive intermediates. According to the invention, the process consists in the liquid/liquid extraction of a triterpene glycosides complex from Hedera Helix plant, in which the alpha-hederin is first separated by a liquid/liquid extraction with ethyl acetate, followed by the separation of bisdesmosidic glycoside compounds Hederacoside C, of which there result two purified preparations, a liquid bioactive complex and an aqueous CuNa-chlorophyl extract. According to the invention, the medicine product comprises 1...2% phytotherapeutic product conditioned with pharmaceutically acceptable ingredients, suitable to the administration type.
Patent LU-76721-A1 (LU)
IPC: B62D5/06
Filed: 1977-02-08
Abstract: An improved fluid flow control apparatus is utilized in association with a vehicle having a single variable displacement pump for supplying fluid to both a steering apparatus and an auxiliary apparatus. The fluid flow control apparatus includes a pair of variable size orifices one of which is associated with the steering apparatus and the other of which is associated with the auxiliary apparatus. Upon actuation of either the steering or auxiliary apparatus, the size of the associated orifice is varied to provide a variation in a load signal and effect a change in the displacement of the pump. During simultaneous operation of both the steering and auxiliary apparatus, a priority valve assembly is utilized to block fluid flow to the auxiliary apparatus if the fluid output from the pump is insufficient to satisfy the demand for steering fluid. The priority valve assembly includes a main valve member with an internal chamber in which a secondary valve member or piston is disposed. Upon initiation of a steering operation with the auxiliary apparatus in an inactive condition, the secondary valve member moves toward a closed position. If at this time the demand for steering fluid is sufficiently great, the secondary valve member blocks fluid flow to the auxiliary apparatus.
Patent MA-21516-A1 (MA)
Inventor: JEAN KOEUR
IPC: A01N25/04
Filed: 1989-03-16
Abstract: New liq. herbicides contain racemic or L-phosphinothricin (I) or its lower alkyl esters or salts with acids or bases in combination with a surface active agent in the form of (a) (12-18C alkyl-dimethyl-, 10-18C fatty acid amidopropyl-dimethyl-or 10-18C fatty acid amidoethyl-dimethyl-amine oxides, (b) the betaine of coco-alkyl-dimethylaminoacetic acid or coco-alkylaminopropionic acid, (c) 12-18C alkanesulphonates and their mixts. with 10-18C fatty alcohol polyglycol ether sulphosuccinic acid half-esters or 10-18C fatty alcohol polyglycol ether sulphates, (d) 12-18C alkyl sulphosuccinic acid half-esters or 10-18C fatty alcohol polyglycol ether sulphosuccinic acid half-esters and esters and their mixts. with 10-18C fatty alcohol polyglycol ether sulphates, or (e) 12-20C alpha-olefin sulphonates and their mixts. with 10-18C fatty alcohol polyglycol ether sulphates, 10-18C fatty alcohol polyglycol ether sulphosuccinic acid half-esters or 12-18 C alkyl sulphosuccinic acid half-esters (sulphonates being alkali, ammonium, alkaline earth or substd. alkyl; or alkanolamine salts of the corresponding sulphonic or sulphuric acids).
Patent MA-27387-A1 (MA)
Title: PRECURSEUR DE MEDICAMENT INHIBITEUR DE BeTA-LACTAMASE
Inventor: MARFAT ANTHONY
IPC: C07D499/00
Filed: 2005-02-23
Abstract: Précurseur de médicament inhibiteur de bêta-lactamase  Des précurseurs médicamenteux de sulfone d'acide 6-(bêta)-hydroxyméthylpénicillanique ayant la structure dans laquelle R représente H ou un groupe méthyle, et leurs produits de solvatation sont décrits. Il est décrit également des compositions pharmaceutiques comprenant un précurseur médicamenteux de la présente invention, ou un de ses produits de solvatation, un antibiotique bêta-lactame facultatif et au moins un support pharmaceutiquement acceptable. Il est décrit en outre une méthode pour accroître l'efficacité thérapeutique d'un antibiotique bêta-lactame chez un mammifère en administrant une quantité efficace d'antibiotique bêta-lactame et une quantité, à effet d'augmentation d'efficacité, d'un précurseur médicamenteux de la présente invention ou d'un de ses produits de solvatation. Il est décrit en outre une méthode pour le traitement d'une infection bactérienne chez un mammifère en administrant une quantité thérapeutiquement efficace d'une composition pharmaceutique de la présente invention à un mammifère nécessitant un tel traitement.
Patent MA-38660-A1 (MA)
Title: Tôle en acier laminée à froid, procédé de fabrication et véhicule
Inventor: MATAIGNE JEAN-MICHEL
IPC: C23C2/06
Filed: 2015-12-10
Abstract: La présente invention concerne une tôle en acier laminée à froid et enduites par immersion à chaud présentant une résistance à la traction supérieure à 1000 - 50xai mpa, un allongement supérieur à 15 % et une faible densité. L'acier comprend, en pourcent en poids : 0,1 = c = 0,5 %, 3,5 = mn = 10,0 %, 0 = al = 9,0%, si = 5,0 %, ti = 0,2 %, v = 0,2 %, nb = 0,2 %, s = 0,004 %, p = 0,025 %, 0,5 = si+ai = 9,0 %, b = 0,0035, cr = 1 %, le reste étant fe et des impuretés et la microstructure contenant 25 % à 90 % de ferrite, 10 % à 50 % d'austénite, des précipités kappa en concentration inférieure à 5 % et de la martensite en concentration inférieure à 25 %. L'acier selon la présente invention présente la capacité à être enduit à l'aide d'oxydation totale.
Patent MA-40676-A1 (MA)
Title: Guide universel d'implantologie
Inventor: EL HAMID ALI
IPC: A61C1/08
Filed: 2017-07-10
Abstract: • guide conçu pour les médecins dentistes lors d'une chirurgie de pose implantaire, • guide conçu pour situer facilement les points d'émergence des implants dentaires avec respect des impératifs biologiques et esthétiques, • images du guide (cf dessin point« e »).
Patent MA-43618-A1 (MA)
Title: Nouveaux peptides, association de peptides en tant que cibles et destinés à être utilisés en immunothérapie contre le cancer de la vésicule biliaire et le cholangiocarcinome et autres cancers
Inventor: WEINSCHENK TONI
IPC: C12N9/12
Filed: 2017-05-23
Abstract: La présente invention concerne des peptides, des protéines, des acides nucléiques et des cellules destinées à être utilisés dans des procédés immunothérapeutiques. L'invention concerne en particulier l'immunothérapie du cancer. La présente invention concerne, en outre, des épitopes peptidiques des lymphocytes t associés à une tumeur, seuls ou en combinaison avec d'autres peptides associés à une tumeur, qui peuvent, par exemple, servir de principes pharmaceutiques actifs de compositions vaccinales qui stim
Patent UY-26273-A1 (UY)
Title: Amidas de acidos carboxilicos, su preparacion y su empleo como medicamentos
Inventor: STASSEN RIES PRIEPKE HECKEL NA
IPC: C07C311/46
Filed: 2000-08-04
Abstract: La presente invención se refiere a amidas de ácidos carboxílicos de la formula general en la que r1 a r4, ar m, y n están definidos como en la reivindicación 1, sus tautomeros, sus estéreo isómeros, sus mezclas, sus pro fármacos y sus sales, que presentan valiosas propiedades. los compuestos de la formula general 1 anterior, en los que r5 representa un grupo ciano, representan valiosos productos intermedios para la preparación de los restantes compuestos de la formula general HI, y los compuestos de la formula general I, en los que r5 representa uno de los grupos amidino mencionados en la reivindicación 1, presentan valiosas propiedades farmacológicas, en particular un efecto antitrombotico y un efecto inhibido del factor xa.-
Patent UY-28202-A1 (UY)
Title: Utilización de esteroides en el tratamiento de personas que sufren trastonos oculares.
Inventor: BINGAMAN DAVID P
IPC: A61K31/573
Filed: 2004-02-19
Abstract: Se describen métodos y composiciones para el tratamiento del edema retinal y la retinopatía diabética no proliferativa.
Patent UY-29091-A1 (UY)
Title: Nueva combinacion antiparasitaria de principios activos
Inventor: GREIF DR GISELA
IPC: A61K31/335
Filed: 2005-08-30
Abstract: La presente invención se refiere al uso combinado de bencimidazoles sustituidos y compuestos de 1,2,4-triazina frente a protozoos parasitarios, en particular coccidios.
Patent ES-173599-A1 (ES)
Title: UN INSTRUMENTO oPTICO DE MEDICIoN DE PARALELAJE, TAL COMO UN TELÉMETRO
Filed: 1946-05-17
Abstract: Instrumento óptico de medición de paralaje tal como un telémetro que tiene dos oculares en que aparecen tres imágenes estando dos de ellas en el campo de un ocular y la tercera ene l otro ocular; siendo un campo del par de uno de los oculares formado por luz de un extremo de la base y los otros dos campos por luz del otro extremo.
Patent ES-177879-A1 (ES)
Title: Un procedimiento para el tratamiento térmico controlado de cuerpos de carbono
IPC: H01R43/12
Filed: 1947-05-03
Abstract: Un procedimiento de tratar al calor rápidamente a cuerpos de carbono verde comprimidos para carbonizarlos virtualmente sin deformación nociva de los mismos y para conseguir propiedades físicas y eléctricas predeterminadas; caracterizado porque se hace pasar una atmósfera de gas controlada virtualmente libre de gases oxidantes sobre los cuerpos de carbono verde mientras éstos se calientan a alta pendiente térmica a temperaturas de tratamiento predeterminado.